Geographical and temporal variation of injection drug users in Pakistan

被引:13
作者
Archibald, Chris P. [1 ]
Shaw, Souradet Y. [2 ]
Emmanuel, Faran [3 ]
Otho, Suleman [3 ]
Reza, Tahira [3 ]
Altaf, Arshad [3 ]
Musa, Nighat [3 ]
Thompson, Laura H. [2 ]
Blanchard, James F. [2 ]
机构
[1] Publ Hlth Agcy Canada, Ctr Communicable Dis & Infect Control, Ottawa, ON, Canada
[2] Univ Manitoba, Ctr Global Publ Hlth, Winnipeg, MB R3E 0T6, Canada
[3] HIV AIDS Surveillance Project, Islamabad, Pakistan
关键词
RISK BEHAVIORS; HIV; HIV/AIDS; INFECTION;
D O I
10.1136/sextrans-2012-050775
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives We describe the characteristics of injecting drug users (IDU) in Pakistan in 2006 and 2011, and assess the heterogeneity of IDU characteristics across different cities and years as well as factors associated with HIV infection. Methods Cross-sectional, integrated behavioural-biological surveys of IDU were conducted in 10 cities across Pakistan in 2006 and 2011. Univariate and multivariable analyses were used to describe the differences in HIV prevalence and risk behaviours between cities and over time. Results Large increases in HIV prevalence among injection drug users in Pakistan were observed, with overall HIV prevalence increasing from 16.2% in 2006 to 31.0% in 2011; an increase in HIV prevalence was also seen in all geographic areas except one. There was an increase in risk behaviours between 2006 and 2011, anecdotally related to a reduction in the availability of services for IDU. In 2011, larger proportions of IDU reported injecting several times a day and using professional injectors, and fewer reported always using clean syringes. An increase in the proportion living on the street was also observed and this was associated with HIV infection. Cities differ in terms of HIV prevalence, risk profiles, and healthcare seeking behaviours. Conclusions There is a high prevalence of HIV among injection drug users in Pakistan and considerable potential for further transmission through risk behaviours. HIV prevention programs may be improved through geographic targeting of services within a city and for involving groups that interact with IDU (such as pharmacy staff and professional injectors) in harm reduction initiatives.
引用
收藏
页码:18 / 28
页数:11
相关论文
共 22 条
[1]   Seroprevalences and co-infections of HIV, hepatitis C virus and hepatitis B virus in injecting drug users in Quetta, Pakistan [J].
Achakzai, Malik ;
Kassi, Masoom ;
Kasi, Pashtoon Murtaza .
TROPICAL DOCTOR, 2007, 37 (01) :43-45
[2]   Variations in the population size, distribution and client volume among female sex workers in seven cities of Pakistan [J].
Blanchard, J. F. ;
Khan, A. ;
Bokhari, A. .
SEXUALLY TRANSMITTED INFECTIONS, 2008, 84 :II24-II27
[3]   RISK-FACTORS AND HIV SEROPOSITIVITY AMONG INJECTING DRUG-USERS IN BANGKOK [J].
CHOOPANYA, K ;
VANICHSENI, S ;
JARLAIS, DCD ;
PLANGSRINGARM, K ;
SONCHAI, W ;
CARBALLO, M ;
FRIEDMANN, P ;
FRIEDMAN, SR .
AIDS, 1991, 5 (12) :1509-1513
[4]   HIV-1 INFECTION AMONG INTRAVENOUS DRUG-USERS IN MANHATTAN, NEW-YORK-CITY, FROM 1977 THROUGH 1987 [J].
DESJARLAIS, DC ;
FRIEDMAN, SR ;
NOVICK, DM ;
SOTHERAN, JL ;
THOMAS, P ;
YANCOVITZ, SR ;
MILDVAN, D ;
WEBER, J ;
KREEK, MJ ;
MASLANSKY, R ;
BARTELME, S ;
SPIRA, T ;
MARMOR, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (07) :1008-1012
[5]  
Emmanuel Faran, 2006, J Pak Med Assoc, V56, P119
[6]   The HIV/AIDS Surveillance Project mapping approach: an innovative approach for mapping and size estimation for groups at a higher risk of HIV in Pakistan [J].
Emmanuel, Faran ;
Blanchard, James ;
Zaheer, Hasan A. ;
Reza, Tahira ;
Holte-McKenzie, Merydth .
AIDS, 2010, 24 :S77-S84
[7]   The newest epidemic: a review of HIV/AIDS in Central and Eastern Europe [J].
Kelly, JA ;
Amirkhanian, YA .
INTERNATIONAL JOURNAL OF STD & AIDS, 2003, 14 (06) :361-371
[8]   High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan [J].
Kuo I. ;
ul-Hasan S. ;
Galai N. ;
Thomas D.L. ;
Zafar T. ;
Ahmed M.A. ;
Strathdee S.A. .
Harm Reduction Journal, 3 (1)
[9]   The global epidemiology of HIV/AIDS [J].
Morison, L .
BRITISH MEDICAL BULLETIN, 2001, 58 :7-18
[10]  
National AIDS Control Program, 2007, HIV 2 GEN SURV PAK N